There’s no doubt that Market Access and Pricing leaders are fast becoming strategic partners in helping their wider organisations to understand the critical role of the function. In this episode, Marco Rauland from Merck KGaA joins us to explore this topic.

Marco is Vice President Global Market Access and Pricing strategy, Pricing and Analytics. With over 25 years' experience in the field, he shares his views on the importance of clear communication when engaging all stakeholders and why MA&P leaders need to take a holistic approach to understanding all corners of drug development and launch. 

We also touch on the potential for AI in market access as the industry begins to explore the use cases of this latest innovation. Plus, the challenges market access leaders are facing and what strategies can help them overcome them.  

The opinions shared in this episode are Marco’s own views and not representative of the organisation he is working for.  

Send us a text